Evidence map›Paper›PMID 41144847›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

A Mathematical Model of Cellular Aggregation Predicts Patterns of Tau Accumulation in Neurodegenerative Disease.

Shih-Huan Huang, Annelies Quaegebeur, Tanrada Pansuwan, Timothy Rittman, Ruiyan Wang, Tuomas Pj Knowles, James B Rowe, David Klenerman, Georg Meisl

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Emerging directions in tauopathy research.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shih-Huan HuangYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.ORCID https://orcid.org/0000-0003-1707-9416
Annelies QuaegebeurDepartment of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, CB2 0SZ, UK.
Tanrada PansuwanDepartment of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, CB2 0SZ, UK.
Timothy RittmanDepartment of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, CB2 0SZ, UK.
Ruiyan WangYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.
Tuomas Pj KnowlesYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.
James B RoweDepartment of Clinical Neurosciences and Cambridge University Hospitals NHS Trust, University of Cambridge, Cambridge, CB2 0SZ, UK.
David KlenermanYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.
Georg MeislYusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.ORCID https://orcid.org/0000-0002-6562-7715

Funding

Alzheimer's Research UK ARUK-PG2020A-009Medical Research Council MC__UU__00030/14Medical Research Council MR/T033371/1NIHR Cambridge Biomedical Research Centre NIHR203312Royal SocietyUK Dementia Research InstituteWellcome TrustWellcome Trust 220258
6 · The paper itself

Abstract

Protein aggregates are a hallmark of neurodegenerative disease, yet the molecular processes that control their appearance remain incompletely characterized. In particular, it is unknown to what degree the development of aggregates in one cell is triggered by nearby aggregate-containing cells, as opposed to proceeding cell-autonomously. Here, a minimal, bottom-up computational model is developed that is characterized by just two parameters: the relative rate of cell autonomous and cell-to-cell triggers of aggregation and a length scale of cell-to-cell interactions. Its applicability is demonstrated in the primary tauopathy Progressive Supranuclear Palsy by extracting mechanistic information from the distribution of tau aggregates at different disease stages from post-mortem human brain. Despite its simplicity, the model is able to reproduce the aggregate patterns observed in the data and reveals that the triggering of aggregation by nearby aggregated cells, over distances of ≈100 µm, is the major driver of disease progression once a low threshold level of aggregates is reached. The model also provides a natural explanation for an increase in the rate of disease progression when this threshold is reached, providing fundamental new insights into disease mechanisms and predicting the efficiency of different therapeutic strategies.

Indexed as

Cell AggregationModels, TheoreticalNeurodegenerative DiseasesProtein AggregatesProtein Aggregation, PathologicalSupranuclear Palsy, ProgressiveTauopathiestau ProteinsBrainDisease ProgressionHumansProtein Aggregatestau Proteinsmechanistic modelmolecular mechanismneurodegenerationprotein aggregationtauopathy

Identifiers

PMID41144847
PMCPMC12767001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.